• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西公共卫生系统中 10 年来视网膜疾病治疗趋势。

Trends in treatment of retinal disorders in the Brazilian Public Health System over a 10-year period.

机构信息

Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

出版信息

Einstein (Sao Paulo). 2021 Dec 10;19:eGS6616. doi: 10.31744/einstein_journal/2021GS6616. eCollection 2021.

DOI:10.31744/einstein_journal/2021GS6616
PMID:34909976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8664286/
Abstract

OBJECTIVE

To investigate trends in terms of number and cost of intravitreal injection, photocoagulation and panphotocoagulation procedures performed by the Brazilian Public Health System, from 2010 to 2019.

METHODS

The Brazilian Public Health System Database was used as the primary source of data. Intravitreal injection, photocoagulation and panphotocoagulation procedures performed from 2010 to 2019 were investigated. Procedure prevalence and cost trends were analyzed according to year and region. Annual trends were examined using generalized linear models, with a significance level of 5% (p=0.05).

RESULTS

There was a significant increase in the prevalence of intravitreal injections (1,088%), panphotocoagulation (51%) and photocoagulation (37%) procedures from 2010 to 2019. Intravitreal injections accounted for the most significant increase. However, costs were not significantly readjusted over the years.

CONCLUSION

Over a 10-year period, there was a significant increase in the number of procedures associated with retinal disorders. Procedure costs saw little readjustments over time. In spite of limitations, inaccuracies and lack of details, the Brazilian Public Health System Database is the primary source of data for the Public Health System related research in Brazil, and can contribute with information on ocular health and costs of ophthalmic procedures.

摘要

目的

调查 2010 年至 2019 年巴西公共卫生系统实施玻璃体腔内注射、光凝和全视网膜光凝手术的数量和成本趋势。

方法

使用巴西公共卫生系统数据库作为主要数据源。调查了 2010 年至 2019 年期间进行的玻璃体腔内注射、光凝和全视网膜光凝手术。根据年份和地区分析了手术的流行率和成本趋势。使用广义线性模型检查年度趋势,显著性水平为 5%(p=0.05)。

结果

2010 年至 2019 年,玻璃体腔内注射(1088%)、全视网膜光凝(51%)和光凝(37%)手术的流行率显著增加。玻璃体腔内注射的增幅最大。然而,多年来成本并没有进行明显调整。

结论

在 10 年期间,与视网膜疾病相关的手术数量显著增加。随着时间的推移,手术成本几乎没有调整。尽管存在局限性、不准确性和缺乏细节,但巴西公共卫生系统数据库是巴西公共卫生系统相关研究的主要数据来源,可提供有关眼部健康和眼科手术成本的信息。

相似文献

1
Trends in treatment of retinal disorders in the Brazilian Public Health System over a 10-year period.巴西公共卫生系统中 10 年来视网膜疾病治疗趋势。
Einstein (Sao Paulo). 2021 Dec 10;19:eGS6616. doi: 10.31744/einstein_journal/2021GS6616. eCollection 2021.
2
Costs and benefits of bevacizumab vial sharing for the treatment of retinal diseases.贝伐单抗瓶共享治疗视网膜疾病的成本和效益。
BMC Public Health. 2019 Sep 11;19(1):1252. doi: 10.1186/s12889-019-7562-y.
3
Penile cancer trends and economic burden in the Brazilian public health system.巴西公共卫生系统中的阴茎癌趋势及经济负担
Einstein (Sao Paulo). 2020 Nov 6;18:eAO5577. doi: 10.31744/einstein_journal/2020AO5577. eCollection 2020.
4
Intravitreal therapy for retinal diseases in Norway 2011-2015.2011-2015 年挪威视网膜疾病的玻璃体腔内治疗。
Acta Ophthalmol. 2020 May;98(3):279-285. doi: 10.1111/aos.14262. Epub 2019 Oct 6.
5
Trends in cataract surgical treatment within the Brazilian national public health system over a 20-year period: Implications for Universal Eye Health as a global public health goal.巴西国家公共卫生系统20年内障手术治疗趋势:对作为全球公共卫生目标的全民眼健康的影响
PLOS Glob Public Health. 2022 Jun 9;2(6):e0000328. doi: 10.1371/journal.pgph.0000328. eCollection 2022.
6
Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV).调查:巴西视网膜与玻璃体协会(SBRV)成员进行玻璃体腔内注射的技术。
Arq Bras Oftalmol. 2015 Jan-Feb;78(1):32-5. doi: 10.5935/0004-2749.20150009.
7
Use of retinal procedures in medicare beneficiaries from 1997 to 2007.1997年至2007年医疗保险受益人中视网膜手术的使用情况。
Arch Ophthalmol. 2010 Oct;128(10):1335-40. doi: 10.1001/archophthalmol.2010.224.
8
SUCCESSFUL TREATMENT OF REFRACTORY PROLIFERATIVE RETINOPATHY OF INCONTINENTIA PIGMENTI BY INTRAVITREAL RANIBIZUMAB AS ADJUNCT THERAPY IN A 4-YEAR-OLD CHILD.玻璃体内注射雷珠单抗作为辅助治疗手段成功治疗一名4岁儿童的难治性色素失禁症增殖性视网膜病变
Retin Cases Brief Rep. 2017;11(4):352-355. doi: 10.1097/ICB.0000000000000369.
9
Resource use and costs of branch and central retinal vein occlusion in the elderly.老年人的分支和中央视网膜静脉阻塞的资源利用和成本。
Curr Med Res Opin. 2010 Jan;26(1):223-30. doi: 10.1185/03007990903439046.
10
Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care.巴西偏头痛负担:偏头痛对公共卫生系统的成本估算及分层护理模式成本效益的分析研究
Headache. 2003 Jul-Aug;43(7):742-54. doi: 10.1046/j.1526-4610.2003.03132.x.

引用本文的文献

1
Automated fluid monitoring to optimize the follow-up of neovascular age-related macular degeneration patients in the Brazilian population.巴西人群中用于优化新生血管性年龄相关性黄斑变性患者随访的自动液体监测。
Int J Retina Vitreous. 2025 Jul 6;11(1):75. doi: 10.1186/s40942-025-00695-0.

本文引用的文献

1
Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options.临床实践中糖尿病性黄斑水肿的管理:当前策略与治疗选择的系统评价和荟萃分析
Clin Ophthalmol. 2021 Jan 29;15:375-385. doi: 10.2147/OPTH.S236423. eCollection 2021.
2
Penile cancer trends and economic burden in the Brazilian public health system.巴西公共卫生系统中的阴茎癌趋势及经济负担
Einstein (Sao Paulo). 2020 Nov 6;18:eAO5577. doi: 10.31744/einstein_journal/2020AO5577. eCollection 2020.
3
Brazilian hospitals' performance: an assessment of the unified health system (SUS).
巴西医院的绩效:对统一卫生系统(SUS)的评估。
Health Care Manag Sci. 2020 Sep;23(3):443-452. doi: 10.1007/s10729-020-09505-5. Epub 2020 May 6.
4
Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach.玻璃体内注射血管内皮生长因子抑制剂:实用方法
Ophthalmol Ther. 2020 Mar;9(1):191-203. doi: 10.1007/s40123-020-00230-4. Epub 2020 Feb 7.
5
Cost Effectiveness of Treatments for Diabetic Retinopathy: A Systematic Literature Review.糖尿病视网膜病变治疗的成本效益:系统文献回顾。
Pharmacoeconomics. 2019 Aug;37(8):995-1010. doi: 10.1007/s40273-019-00800-w.
6
Monotherapy laser photocoagulation for diabetic macular oedema.糖尿病性黄斑水肿的单药激光光凝治疗
Cochrane Database Syst Rev. 2018 Oct 15;10(10):CD010859. doi: 10.1002/14651858.CD010859.pub2.
7
Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病:临床实践指南
J Ophthalmic Vis Res. 2018 Apr-Jun;13(2):158-169. doi: 10.4103/jovr.jovr_50_18.
8
Projection of Eye Disease Burden in Singapore.新加坡眼部疾病负担预测。
Ann Acad Med Singap. 2018 Jan;47(1):13-28.
9
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.糖尿病视网膜病变、糖尿病性黄斑水肿及相关视力丧失的流行病学
Eye Vis (Lond). 2015 Sep 30;2:17. doi: 10.1186/s40662-015-0026-2. eCollection 2015.
10
[The cost of tobacco-related diseases for Brazil's Unified National Health System].[巴西统一国家卫生系统中与烟草相关疾病的成本]
Cad Saude Publica. 2010 Jun;26(6):1234-45. doi: 10.1590/s0102-311x2010000600016.